You are here: All Products  > Ascletis Starts China Bridging Trial of FXR Agonist for Hepatitis B

Ascletis Starts China Bridging Trial of FXR Agonist for Hepatitis B

Price: $5.00
Available

Get instant access to this article for unlimited viewing and/or downloading for seven days.


Back to products